日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2016/07/12 | 05 : 23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/07/12 | 01 : 10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/07/06 | 06 : 02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/30 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/30 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/30 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/30 | 19 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 04 : 37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 04 : 05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 04 : 00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 50 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/25 | 03 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 34 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 27 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 25 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |
2016/06/24 | 22 : 23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ANAC | Anacor Pharmaceuticals, Inc. |